Picture of Laboratorios Farmaceuticos Rovi logo

ROVI — Laboratorios Farmaceuticos Rovi News Story

0.000.00%
es flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Brief: Rovi FY Net Profit At 136.9 Mln Euros

Feb 25 (Reuters) - Laboratorios Farmaceuticos ROVI SA
 ROVI.MC :
    * FY REVENUE 763.7 MILLION EUROS
    * FY NET PROFIT 136.9 MILLION EUROS
IS UNABLE TO FORECAST HOW DEMAND AND PRODUCTION MIGHT EVOLVE FOR
VACCINATION CAMPAIGNS THAT WILL TAKE PLACE IN 2025
    * FY EBITDA 244.5 MILLION EUROS
    * SEES 2025 OPERATING REVENUE TO DECREASE BY
MID-SINGLE-DIGIT
PERCENTAGE VERSUS 2024

Source text:  ID:nCNMc1JhkN 
Further company coverage:  ROVI.MC 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Laboratorios Farmaceuticos Rovi

See all news